BioSeek is a drug discovery services company that applies human primary cell assays and predictive disease models to the discovery and development of human therapeutics and safer chemicals.
BioSeek improves the success rate of drug discovery and development by integrating human biology from the earliest stages of drug discovery onward through its unique BioMAP® platform. Our mission is to accelerate drug compound validation and enable our clients to take safer and more effective products into the market.

Founded in 2000, BioSeek has established a leadership position by combining proprietary technologies and extensive know-how for pre-clinical modeling of human biology.

BioSeek is based in South San Francisco, California.

http://bioseekinc.com/




Asterand shareholders approve delisting
StockMarketWire.com
Asterand (LON:ATD) has announced that all resolutions put to the Annual General Meeting held today were duly passed, with the exception of resolution 6. Resolution 6 was in respect of the disapplication of pre-emption rights.

Further to the announcement made on 13 July 2012, the Board has also announced announce that all Resolutions put to the General Meeting held today were duly passed.

The Company will therefore proceed with the proposals to: (i) dispose of the Human Tissue Business; (ii) cancel the listing of the Ordinary Share on the Official List and the admission to trading of the Ordinary Shares on the Main Market of the London Stock Exchange; and, (iii) change the name of the Company to BioSeek plc.

Completion of the Disposal and the settlement of the Secured Debt is expected to occur in the next few days. The change of name to BioSeek plc expected to occur on or around 3 August 2012 at which time the Company's website will also change. Further announcements will be made in due course.

It is expected that the last day of dealing in the Ordinary Shares on the Main Market will be 28 August 2012. Cancellation of the listing of Ordinary Shares on the Official List and the admission to trading of the Ordinary Shares on the Main Market of the London Stock Exchange is expected to take effect at 8.00 a.m. on 29 August 2012.

23% rise today, last day of trading. Then tomorrow on the main market

wow what a drop